Introduction
Clostridium difficile is known to release two exotoxins, toxin A and toxin B, which cause acute inflammation in the gut [1] [2] [3] [4] [5] [6] . In rabbits and mice, these toxins cause acute enteritis via a rapid inflammatory response that involves lymphocytes and the secretion of proinflammatory cytokines [7] [8] [9] [10] [11] [12] . Inflammatory responses in the gut have been strongly associated with mucosal epithelial cell apoptosis, and C. difficile toxins are known to markedly increase the apoptosis of gut epithelial cells [4] [5] [6] 13] . The barrier function of epithelial cells itself affects mucosal permeability and regulates the exposure of luminal contents to the body system [13, 14] . Thus, the change in the permeability of the mucosal layer triggered by toxin-induced epithelial cell apoptosis is considered to be a critical factor in severe gut inflammation [4] [5] [6] 14] . Together, these concepts support the notion that inhibiting toxin-induced epithelial cell apoptosis and barrier dysfunction could be a good therapeutic approach. We thus urgently need to isolate new agents that are capable of blocking toxin-induced cell apoptosis if we hope to cure gut inflammation-associated diseases such as pseudomembranous colitis.
C. difficile toxin A-induced colonic epithelial cell apoptosis is known to be highly dependent on the intercellular levels of reactive oxygen species (ROS) [4] [5] [6] . Toxin A mediates a rapid generation of ROS that was shown to activate p38MAPK and induce the expression of p21
these factors are essential mediators of apoptosis in colonic epithelial cells [15, 16] . SB203580 (a chemical inhibitor of p38MAPK) was shown to inhibit toxin A-induced cell apoptosis in cultured human colonocytes and the toxin Ainduced mouse model of acute enteritis [5] . In pseudomembranous colitis, the rate of apoptosis among mucosal epithelial cells is markedly increased [17] . Additionally, the therapeutic effect of TNF-α-neutralizing antibodies on inflammatory bowel disease is associated with the antiapoptotic role of TNF-α: restoring barrier function by downregulating epithelial cell apoptosis ameliorates inflammatory responses [17] . The American cockroach, Periplaneta americana Linnaeus, appeared 320 million years ago and is among the strongest and oldest organisms in existence [18] . It has been widely studied in the fields of neurobiology, reproductive physiology, and social behavior [19] . In recent years, researchers have begun examining the potential clinical uses of extracts from this organism [18, 19] . Crude extracts of the American cockroach have been reported to show significant anticancer effects [20] , exhibit anti-inflammatory actions [21] , promote tissue regeneration, improve immunity, and show specific curative effects on gastrointestinal mucosal barrier function [22] .
We recently isolated a 15-mer peptide from the American cockroach, showed that it has antimicrobial activity, and designated it Periplanetasin-2 (Peri-2, YPCKLNLKLGKVPFH). Based on previous findings that antimicrobial peptides exhibit various biological effects against mammalian cells [23] , we herein assessed whether Peri-2 could inhibit the epithelial damage and inflammation induced by C. difficile toxin A. Our results revealed that Peri-2 can inhibit toxin A-induced cellular toxicity in HT29 cells and ameliorate toxin A-induced enteritis in mice. These findings suggest that Peri-2 could be a new potential agent for remitting/ curing the gut inflammation induced by C. difficile toxin A.
Materials and Methods

Synthesis of Peri-2
The Peri-2 peptide (15-mer (YPCKLNLKLGKVPFH), from the American cockroach Periplaneta americana Linnaeus) was synthesized by AnyGen (Korea). The C-terminus of the peptide was synthesized as an amide to neutralize the negative charge created by the Cterminal COOH and prevent enzyme degradation [13, [24] [25] [26] . The peptide was purified by reverse-phase high-performance liquid chromatography (HPLC) using a Capcell Pak C18 column (Shiseido, Japan) and eluted with a linear gradient of wateracetonitrile (0-80%) containing 0.1% trifluoroacetic acid (45% recovery).
Cells and Reagents
Human colorectal adenocarcinoma HT29 cells were grown in McCoy's 5A medium (Invitrogen, USA) supplemented with 10% fetal bovine serum, 1% penicillin (Gibco, USA) and 1% streptomycin (Invitrogen), and cultured at 37 o C in a humidified incubator containing 5% CO 2 [4, 5] . The polyclonal antibodies against phospho-p38MAPK and caspase-3 were purchased from Cell Signaling Technology (USA). The antibody against p21
and the propidium iodide were obtained from Santa Cruz Biotechnology (USA). The antibody against β-actin, the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide MTT), and the 2,7-dichlorofluorescin-diacetate (DCF-DA) were purchased from Sigma-Aldrich (USA).
Clostridium difficile Toxin A Preparation Cells of C. difficile strain VPI 10463 (American Type Culture Collection) were incubated at 37 o C for more than 2 weeks and then centrifuged for 30 min at 8,000 rpm at 4 o C. Toxin A was purified as previously described [4, 5] .
Cell Viability
HT29 cells treated with the various agents were incubated with MTT dye for 2 h. For solubilization, dimethyl sulfoxide was added, and the absorbance was determined at 570 nm in a microplate reader (Model 3550; Bio-Rad, Canada) [24] .
Determination of Reactive Oxygen Species
HT29 cells were plated to optical-quality plastic-bottom 96-well microplates, treated with Peri-2 (10 μg/ml) for 30 min, incubated with DCF-DA (50 μM) for 15 min, and further incubated with 3 nM toxin A with or without Peri-2 for 15 min. The cells were subjected to examination of DCF fluorescence using a fluorimeter (Ascent FL; Lab Systems) at wavelengths of 485 nm for excitation and 538 nm for emission [5] .
Clostridium difficile Toxin A-Induced Acute Mouse Enteritis
Mice were anesthetized by intraperitoneal injection of sodium pentobarbital (50 mg/kg). Ileal loops (3 cm) were prepared by silk ligation and lumenally injected with PBS alone, or with toxin A (3 nM) plus PBS or 10 μg/ml of Peri-2. After 4 h, the mice were sacrificed and the ileal loop tissues were collected for evaluation of mucosal damage and acute inflammatory responses. To evaluate inflammation, the ileal loops were washed in cold PBS and homogenized in cold PBS. Supernatants were collected, and mouse IL-6 was measured using an ELISA kit (R&D Systems, USA). This study was approved by the Animal Care and Use Committee of Daejin University (ACUC, Korea) [5, 24] .
TUNEL Assay
HT29 cells were incubated with medium, toxin A, or toxin A plus Peri-2. After 48 h, the cells were fixed with 4% paraformaldehyde in PBS for 15 min at room temperature, and subjected to TUNEL staining using a commercially available kit (Promega, USA). The
results were observed under an Eclipse E600 epifluorescence microscope [26] .
Statistics
All values are presented as mean values ± SEM. All data analyses were performed using SIGMA-STAT Professional for Windows (Sigma Stat, USA). For intergroup comparison, analysis of variance was performed using Dunnett's test [7] .
Results and Discussion
Peri-2 Recovers the Cell Viability Loss and Cell Proliferation Reduction Seen in Toxin A-Treated Human Colonocytes
We recently isolated a 15-mer peptide (YPCKLNLKL GKVPFH) from the American cockroach (Fig. 1A) and named it Periplanetasin-2. Given that extracts of American cockroach have shown therapeutic effects on inflammatory responses and mucosal barrier function in the gastrointestinal tract [21] , we herein assessed whether Peri-2 could block various C. difficile toxin A-induced cell toxicities in human colonocytes. We treated human colonocyte HT29 cells with Peri-2 (10 μg/ml) for 1 h, further incubated the cells with medium or toxin A (3 nM) with or without Peri-2 for 48 h, and then assessed cell proliferation with a BrdU uptake analysis. As shown in Fig. 1B , toxin A treatment reduced cell proliferation by 65%, but this effect was recovered by 30% upon Peri-2 pretreatment. As the insect peptide CopA3 (a Korean dung beetle-derived antimicrobial peptide) was shown to cause cell apoptosis of cancerous cells [26] , we assessed whether Peri-2 caused cell toxicity in human colonocytes. Our MTT assay revealed that Peri-2 treatment slightly increased cell viability in human colonocytes (Fig. 1C) , suggesting that there was no issue with toxicity. There was also no apparent change in the cell shape of epithelial cells following Peri-2 treatment (data not shown). These findings suggest that Peri-2 has no toxicity against human colonocytes, and that it appears to decrease the ability of toxin A to inhibit the proliferation of such cells.
Peri-2 Inhibits Toxin A-Induced Cell Apoptosis
Since C. difficile toxin A is known to cause cell apoptosis in human colonocytes [4] [5] [6] , we examined whether Peri-2 could block the ability of toxin A to induce apoptosis in HT29 cells. We pretreated cells with Peri-2 (10 μg/ml) for 1 h, incubated them with medium or 3 nM toxin A with or without Peri-2 for 48 h, and then performed TUNEL assays. As shown in Fig. 2A , toxin A-treated HT29 cells showed a marked increase in TUNEL-positive cells compared with the control, but the addition of Peri-2 markedly decreased the number of TUNEL-positive cells seen in toxin A-treated cultures. Since caspase-3 plays a key role in cell apoptosis [27] , we next examined whether Peri-2 treatment could inhibit the activation of caspase-3 in human colonocytes. Indeed, toxin A induced the activation of caspase-3, but this effect was significantly inhibited by Peri-2 pretreatment (Fig. 2B, upper) . The activation of caspase-3 was normalized to the levels of β-actin through densitometry quantitation (B) HT29 cells were grown on coverslips, pretreated with Peri-2 for 1 h, and further incubated with medium (con), toxin A alone (Tx; 3 nM), or toxin A plus Peri-2 (10 μg/ml) (Tx + Peri-2) for 48 h. Cell proliferation was measured by BrdU incorporation. The results represent the mean ± SEM from three independent experiments performed in triplicates (* p < 0.01). (C) Cells were treated with Peri-2 for 48 h, cell viability was measured by MTT assay. The results are expressed as a percentage, and represent the means ± SEM from three experiments performed in triplicates.
( Fig. 2B, lower) . Peri-2 alone had no effect on the activation of caspase-3 (data not shown).
The Korean dung beetle-derived peptide CopA3 was reported to cause apoptosis of leukemia cells while sparing non-blood cells [26] , and insect peptides have been shown to activate different signaling pathways in various cell types [13, [24] [25] [26] 28] . These findings suggest that an insect peptide may undergo specific interactions with receptors on target cells. Although we do not yet know which plasma membrane receptor is responsible for the binding of Peri-2 to colonocytes, we speculate that negatively charged components of the cell membrane may interact with the four positively charged amino acids of the Peri-2 peptide sequence (YPCKLNLKLGKVPFH).
Peri-2 Reduces Toxin A-Induced Signaling in Human Colonocytes
The toxin A-induced generation of ROS critically activates downstream signaling molecules, thereby triggering colonic epithelial cell toxicity [4, 5] . To assess whether Peri-2 decreases the ability of toxin A to stimulate ROS generation, we pretreated HT29 cells with Peri-2 (10 μg/ml) for 30 min, and then incubated the cells with medium or 3 nM toxin A with or without Peri-2 for 15 min. Toxin A exposure markedly increased ROS production as expected, but this effect was significantly inhibited by Peri-2 pretreatment (Fig. 3A) . Notably, Peri-2 also decreased the basal level of ROS, suggesting that it has a strong ROS-scavenging activity. The Peri-2 peptide contains a cysteine in its carboxyl region, which could enable it to scavenge ROS through thiol-disulfide exchange activity [29] . To test this possibility, we measured the hydrogen peroxide (H at 230 nm, as previously described [30] . However, Peri-2 did not appear to have any ability to directly scavenge H 2 O 2 (data not shown). Many studies have found that toxin A activates p38MAPK and upregulates p21
, and that these responses are highly dependent on ROS production in human colonocytes [4, 5] . Given our finding that Peri-2 inhibits toxin Ainduced ROS production, we next assessed whether Peri-2 inhibits the toxin A-induced increases in p38MAPK activation and p21
expression. We pretreated HT29 cells with Peri-2 for 1 h, incubated the cells with medium or toxin A alone with or without Peri-2 for 3 h, and then assessed p38MAPK activity and p21
expression. As shown in Fig. 3B , toxin A induced the activating phosphorylation of p38MAPK, but this effect was significantly and dose-dependently blocked by Peri-2. Similarly, the expression of p21
was increased by toxin A, and this effect was markedly reduced by Peri-2 treatment (Fig. 3B) . The activating phosphorylation of the erythropoietin receptor was previously shown to be (A) HT29 cells were pretreated with Peri-2 (10 μg/ml) for 1 h, and further incubated with medium (con), toxin A alone (Tx, 3 nM), or toxin A plus Peri-2 (Tx + Peri-2). At 48 h post-treatment, DNA fragmentation was detected by TUNEL assay (white spots indicate apoptosis). The presented results are representative of three independent experiments. (B) Cells were treated as described above. After 48 h, caspase-3 activity was assessed by immunoblotting. Quantitative densitometry from three separate experiments is provided in the graph (* p < 0.05).
inhibited by toxin A in human colonocytes [31] , but this effect was not recovered by Peri-2 treatment in our system. Together, our results indicate that the Peri-2-mediated inhibition of ROS production and subsequent inactivation of p38MAPK and p21
are highly associated with its ability to block the cell damage caused by toxin A.
Peri-2 Ameliorates Toxin A-Induced Inflammation in a Mouse Enteritis Model
Next, we investigated whether Peri-2 could inhibit the toxin A-induced inflammatory response in the mouse gut. We prepared ileal loops in mice, injected the loops with 100 μl of PBS or toxin A (3 nM) with or without Peri-2 (10 μg/ml), and at 4 h post-injection, examined various parameters. As shown in Fig. 4A , Peri-2 treatment significantly reduced the mucosal damage caused by toxin (A) Ileal loops of mice were prepared and injected with PBS alone (con), or with toxin A (3 nM) plus PBS (Tx) or 10 μg/ml of Peri-2 peptide (Tx + Peri-2). After 4 h, the conditioned ileal tissue samples were recovered, fixed, subjected to H&E staining, and then examined under light microscopy (×200). The results shown are representative of three independent experiments. (B) The concentration of IL-6 was measured by ELISA. The bars represent the mean ± SEM from three independent experiments performed in triplicates (* p < 0.05).
A [10] and decreased the toxin A-induced up-regulation of the proinflammatory cytokine IL-6 [4, 24] (Fig. 4B) . These results suggest that Peri-2 could ameliorate toxin A-induced mucosal damage and inflammatory responses in the mouse gut.
Extracts of the American cockroach have previously been shown to suppress the activation of various immune cells, including neutrophils and macrophages [21, 22] . This suggests that Peri-2 may directly inhibit immune cells to affect inflammation in the gut. Indeed, the Korean dung beetle-derived peptide CopA3 was shown to inhibit various LPS-induced effects, including macrophage activation, IL-6 production, TNF-α production, and phagocytosis [32] . Therefore, the therapeutic effect of Peri-2 on mouse gut inflammation is possibly associated with at least two mechanisms: the ability of Peri-2 to suppress toxin Ainduced immune cell-mediated inflammatory responses, and the ability of Peri-2 to restore toxin A-induced epithelial cell damage. This concept is supported by the previous report that CopA3 increases colonic epithelial cell proliferation, which is known to enhance mucosal barrier function and thereby inhibit the gut inflammation caused by various pathogenic factors [24] .
Taken together, our results show that Peri-2 inhibits the cell proliferation decrease and cell apoptosis caused by toxin A in human colonocytes. These inhibitory effects of Peri-2 were found to be highly dependent on its ability to scavenge ROS. Our results indicate that the Peri-2 peptide could be a possible drug candidate for improving toxin Ainduced mucosal damage and inflammatory responses in the gut.
